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radiotherapy of the conduit. Half your lesions were in the upper
half of the esophagus, so I would doubt whether your conduit,
which I assume was the stomach, was included in the radiotherapy
field. Therefore one would have to conclude that the anastomotic
leak rate cannot be correlated to radiotherapy of the conduit.
Dr Swisher: It is important to realize that one can be fooled by
endoscopic ultrasonography, because a mass on endoscopic ultra-
sonography does not always represent viable tumor. We have had
patients with a large mass that was pathologically only T1 or T2.
Additionally, this experience was gained over a long period, so it
is only recently that we have had a chance to review it and see how
strikingly the long-term survival is related to the pathologic spec-
imen. This question gets to the problem again that it is very diffi-
cult at present to clinically stage these relapsed tumors. Perhaps in
the future positron-emission tomography or other noninvasive
staging modalities will improve the staging.
In terms of the fields of radiation that were delivered, they were
delivered at outside hospitals, so it was not possible to evaluate
them and correlate them with the leaks. A number of patients had
distal esophageal tumors, and we have not looked at whether the
leaks occurred primarily among those patients.
Dr Kirby. I would agree with your comments on endoscopic
ultrasonography, but it would still provide the surgeon with addi-
tional information regarding operability. I have just one follow-up
question. If you do not trust the results of endoscopic ultrasonog-
raphy, do you think that there is a role for thoracoscopy? If you
took a biopsy from a lymph node thoracoscopically and found it to
represent N1 or N2 disease, would you still consider that patient a
candidate for an esophagectomy, because you did not have any
long-term survivors in that group of patients?
Dr Swisher. That is a good point, and thoracoscopy may be
valuable in that situation. Again, we have to be cautious because
the risks of thoracoscopy and laparoscopy may also be higher for
these patients. It is important to realize that this is a small study
with only 13 cases acquired over a long period. We really need to
have a prospective study in which we can carefully evaluate these
patients in a controlled fashion to pick out which factors are
important.
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